We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current 0OB3 market cap is 479.94M. The company's latest EPS is EUR -0.7302 and P/E is -4.63.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 137.71M | 129.62M | 371.72M | 376.84M | 175.73M |
| Operating Income | 855k | -55.24M | -61.35M | -113.4M | -82.07M |
| Net Income | -1.74M | -64.39M | -73.43M | -143.28M | -101.43M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 264.72M | 449.16M | 817.35M | 621.34M | 460.06M |
| Total Liabilities | 129.57M | 371.74M | 646.77M | 401.55M | 331.82M |
| Total Equity | 135.15M | 77.42M | 170.58M | 219.8M | 128.25M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | 5.53M | 137.74M | 76.9M | -245.34M | -202.74M |
| Investing | -10.69M | -19.34M | -93.12M | -29.05M | -20.58M |
| Financing | -7.7M | 21.74M | 154.5M | 215.12M | 63.08M |
| Market Cap | 479.94M |
| Price to Earnings Ratio | -4.63 |
| Price to Sales Ratio | 2.67 |
| Price to Cash Ratio | 3.72 |
| Price to Book Ratio | 3.66 |
| Dividend Yield | - |
| Shares Outstanding | 138.91M |
| Average Volume (1 week) | 44.34k |
| Average Volume (1 Month) | 38.27k |
| 52 Week Change | 0.00% |
| 52 Week High | 3.455 |
| 52 Week Low | 3.455 |
| Spread (Intraday) | 0.17 (4.8%) |
| Company Name | Valneva Se |
| Address |
6 rue alain bombard saint-herblain, loire-atlantique 44800 |
| Website | https://www.valneva.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
